Niagen Bioscience Executive Receives 2026 Annette Dickinson Trailblazer Award
Niagen Bioscience said Andrew Shao, Ph.D., has been named the 2026 winner of the Annette Dickinson Trailblazer Award. The recognition comes from Radicle Science and the Council for Responsible Nutrition and highlights his contributions to healthy aging. Shao serves as the company's Senior Vice President of Global Regulatory and Scientific Affairs.
Niagen Bioscience, traded on Nasdaq under NAGE, describes itself as a global authority on NAD+ and focuses on healthy-aging science. The company announced that Andrew Shao, Ph.D., its Senior Vice President of Global Regulatory and Scientific Affairs, received the 2026 Annette Dickinson Trailblazer Award from Radicle Science and the Council for Responsible Nutrition.
Shao described the recognition as especially meaningful to him personally. The honor arrives from two organizations active in nutrition science and supplement standards, and the company linked it to his contributions in healthy aging.
The award may draw more attention to NAD+ research and the regulatory side of the healthy-aging supplement market. Consumers, researchers, and companies working on longevity products could see heightened scrutiny and interest, since recognition from industry groups can shape how such ingredients are perceived. For older adults considering NAD+ supplements, clearer scientific and regulatory signals may influence purchasing decisions, though the award itself does not establish clinical benefit.